Treatment response lowers tumor symptom burden in recurrent and/or metastatic head and neck cancer

Treatment response lowers tumor symptom burden in recurrent and/or metastatic head and neck cancer

Abstract Background Head and neck squamous cell cancer (HNSCC) frequently causes severe symptoms that may be reduced, when the tumor is successfully treated. The SOCCER trial studied the association of treatment response with patient reported tumor symptom burden in first line treatment of recurrent...

Full description

Bibliographic Details
Main Authors: Markus Hecht, Dennis Hahn, Philipp Wolber, Matthias G. Hautmann, Dietmar Reichert, Steffi Weniger, Claus Belka, Tobias Bergmann, Thomas Göhler, Manfred Welslau, Christina Große-Thie, Orlando Guntinas-Lichius, Jens von der Grün, Panagiotis Balermpas, Katrin Orlowski, Diethelm Messinger, Karsten G. Stenzel, Rainer Fietkau
Format: Article
Language:English
Published: BMC 2020-09-01
Series:BMC Cancer
Subjects:
Symptom
Response
HNSCC
Cetuximab
Chemotherapy
Online Access:http://link.springer.com/article/10.1186/s12885-020-07440-w

Internet

http://link.springer.com/article/10.1186/s12885-020-07440-w

Similar Items